Better Quality of Life for People Living with Diabetes Through Validated Innovative Artificial Intelligence Applications
About Melissa
MELISSA aims to innovate diabetes treatment and care for people with insulin-treated diabetes through the development of a clinically validated, efficient and cost-effective Artificial Intelligence-based digital diabetes management solution. This will contribute to every person with insulin-treated diabetes receiving tailored treatment and care according to their individual needs, habits and evolution resulting in a better quality of life.
Start Date1 June 2022
Duration4 Years
Budgetapprox. 8 Mil. €
12 Partners7 Countries
“Now is the time that we combine forces to relieve people with diabetes on insulin from the burden of managing daily blood glucose highs and lows.”
Bastiaan de Galan, MELISSA Coordinator
Universiteit Maastricht, The Netherlands
“A unique opportunity to offer a validated solution for personalized treatment to all patients who do not have the privilege to be equipped with a closed loop.”
Stephan Proennecke, Project Manager & Director
Industrialization at Debiotech S.A., Switzerland
“Transparent, trustworthy, validated, and unbiased AI tools have the potential to transform and revolutionise diabetes management.”
Prof. Dr Stavroula Mougiakakou, AI in Health and Nutrition Laboratory
ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland
News & Events
Follow us
on Twitter
Follow us
on LinkedIn
